- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 401/00 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patent holdings for IPC class C07D 401/00
Total number of patents in this class: 707
10-year publication summary
46
|
14
|
19
|
20
|
19
|
10
|
25
|
11
|
21
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Merck Sharp & Dohme LLC | 3751 |
27 |
Boehringer Ingelheim International GmbH | 4697 |
19 |
Bristol-myers Squibb Company | 4879 |
16 |
Merck Sharp & Dohme Corp. | 2200 |
15 |
Janssen Pharmaceutica N.V. | 3396 |
15 |
Vertex Pharmaceuticals Incorporated | 1595 |
14 |
Takeda Pharmaceutical Company Limited | 2712 |
10 |
Merck Patent GmbH | 5873 |
9 |
Abbvie Inc. | 1800 |
9 |
Theravance Biopharma R&D IP, LLC | 460 |
8 |
Novartis AG | 10886 |
7 |
BASF SE | 20892 |
6 |
Pfizer Inc. | 3379 |
6 |
FMC Corporation | 847 |
6 |
Syntrix Biosystems, Inc. | 30 |
6 |
Universidade Federal do Rio de Janeiro-ufrj | 87 |
6 |
Sanofi | 4036 |
6 |
Glaxosmithkline LLC | 538 |
5 |
Hoffmann-La Roche Inc. | 3404 |
5 |
Bayer Cropscience AG | 2051 |
5 |
Other owners | 507 |